• Product NameLevodopa
• Brief DescriptionInhibitors
• Purification99.64%
• Biological ActivityL-DOPA is a natural form of DOPA used in the treatment of Parkinson's disease. L-DOPA  is the precursor of dopamine and product of tyrosine hydroxylase.
• Target NameDopamine Receptor agonist
• CAS No. 59-92-7
• Calculated MW 197.19
• Formulation C9H11NO4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
  Pathways:GPCR/G Protein; Neuroscience
  Receptor:Dopamine
  Boling pt:
  Melting pt:276-278C
  Solubility:Ethanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)
  Appearance:White Crystal
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Onofrj M, et al. Expert Opin Investig Drugs. 2008 Jul; 17(7):1115-25.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting